Analysis of cytogenetic effects and DNA adduct formation induced by safrole in Chinese hamster lung cells

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 17, Issue 1, 1997, Pages 7-18

  Daimon, Hirohiko ^a   Sawada, Shigeki ^a   Asakura, Shoji ^a   Sagami, Fumio ^a  

^a EISAI CO LTD   (Japan)

Author keywords

Chinese hamster lung cells; Chromosomal aberration; DNA adduct; Safrole; Sister chromatid exchange

Indexed keywords

DEOXYGUANOSINE PHOSPHATE; GUANINE DERIVATIVE; PHOSPHORUS 32; SAFROLE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATTLE; CELL CULTURE; CHINESE HAMSTER; CHROMOSOME ABERRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOGENETICS; DNA ADDUCT; FEMALE; LIVER; LUNG ALVEOLUS CELL; METABOLIC ACTIVATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE; SUPERNATANT; THYMUS;

ANIMALS; CARCINOGENS; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CRICETINAE; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; ISOTOPE LABELING; LUNG; MESOCRICETUS; MUTAGENICITY TESTS; PHOSPHORUS RADIOISOTOPES; SAFROLE; SISTER CHROMATID EXCHANGE;

ANIMALIA; BOS TAURUS; CRICETINAE; CRICETULUS GRISEUS;

EID: 0030765286     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6866(1997)17:1<7::AID-TCM3>3.0.CO;2-L     Document Type: Article

References (36)

1. Furia TE, Bellanca N: "Fenaroli's Handbook of Flavor Ingredients." 2nd Ed. Vol. 2. Cleveland: CRC Press, 1975.
2. Leung AY: "Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics." New York. John Wiley & Sons, 1980.
3. Long EL, Nelson AA, Fitzhugh OG, Hansen WH: Liver tumors produced in rats by feeding safrole Arch Pathol 75:595-604, 1963.
4. Miller EC, Swanson AB, Phillips DH, Fletcher TL, Liem A, Miller JA: Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res 43:1124-1134, 1983.
5. Ioannides C, Delaforge M, Parke DV: Safrole: Its metabolism, carcinogenicity and interactions with cytochrome P-450. Food Cosmet Toxicol 19:657-666, 1981.
6. Miller JA, Miller EC: The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens: Recent results with ethyl carbamate and the spice flavors safrole and estragole. The 1983 Walter Hubert Lecture. Br J Cancer 48:1-15, 1983.
7. Boberg EW, Miller EC, Miller JA, Poland A, Liem A: Strong evidence from studies with brachymorphic mice and pentachlorophenol that I′-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of I′-hydroxysafrole in mouse liver. Cancer Res 43:5163-5173, 1983.
8. Gocke E, King MT, Eckhardt K, Wild D: Mutagenicity of cosmetics ingredients licensed by the European communities. Mutat Res 90:91-109, 1981.
9. Mirsalis JC, Tyson K, Butterworth BE: Detection of genotoxic carcinogens in the in vivo-in vitro hepatocyte DNA repair assay. Environ Mutagen 4:553-562, 1982.
10. Epstein SS, Arnold E, Andrea J, Bass W, Bishop Y: Detection of chemical mutagens by the dominant lethal assay in the mouse. Toxicol Appl Pharmacol 23:288-325, 1972.
11. Topham JC: Do induced sperm-head abnormalities in mice specifically identify mammalian mutagens rather than carcinogens? Mutat Res 74:379-387, 1980.
12. Baker RSU, Bonin AM: Tests with the Salmonella plate-incorporation assay. In Ashby J, De Serres FJ: "Evaluation of Short-Term Tests for Carcinogens." New York: Elsevier, 1985, pp 177-180.
13. Ishidate M, Sofuni T: The in vitro chromosomal aberrations test using Chinese hamster lung (CHL) fibroblast cells in culture. In Ashby J, De Serres FJ: "Evaluation of Short-Term Tests for Carcinogens." New York: Elsevier, 1985, pp 427-432.
14. Van Vent GF: The test for sister-chromatid exchanges in Chinese hamster V79 cells in culture. In Ashby J, De Serres FJ: "Evaluation of Short-Term Tests for Carcinogens." New York: Elsevier, 1985, pp 469-477.
15. Bradley MO: Measurement of DNA single-strand breaks by alkaline elution in rat hepatocytes. In Ashby J, De Serres FJ: "Evaluation of Short-Term Tests for Carcinogens." New York: Elsevier, 1985, pp 353-357.
16. Myhr B, Bowers L, Caspary WJ: Assays for the induction of gene mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells in culture. In Ashby J, De Serres FJ: "Evaluation of Short-Term Tests for Carcinogens." New York: Elsevier, 1985. pp 555-568.
17. Wogan GN, Gorelick NJ: Chemical and biochemical dosimetry of exposure to genotoxic chemicals. Environ Health Perspect 62:5-18, 1985.
18. Yuspa SH, Poirier MC: Chemical carcinogenesis: From animal models to molecular models in one decade. Adv Cancer Res 50:25-70, 1988.
19. Hemminki K: DNA adducts, mutations and cancer. Carcinogenesis 14:2007-2012, 1993.
20. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7:1543-1551, 1986.
21. 32P-postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis 3:1081-1092, 1982.
22. 32P-postlabeling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice. Carcinogenesis 5:1613-1622, 1984.
23. Gail TA, James WA, Carolyn LD, Eugene E, George GH, Martha MM, Yousef S, Dezider G, Stephen N: Relationships between benzo(a)pyrene-DNA adduct levels and genotoxic effects in mammalian cells. Cancer Res 47:3388-3395, 1987.
24. Kalyani P: The relationship between the levels of DNA-hydrocarbon adducts and the formation of sister-chromatid exchanges in Chinese hamster ovary cells treated with derivatives of polycyclic aromatic hydrocarbons. Mutat Res 129:365-372, 1984.
25. Robert HH, Suzanne MM, David TB, Lynda JM, James JC, Frederick AB: Relationships between the DNA adducts and the mutations and sister-chromatid exchanges produced in Chinese hamster ovary cells by N-hydroxy-2-aminofluorene, N-hydroxy-N′-acetylbenzidine and 1-nitrosopyrene. Mutagenesis 1:201-206, 1986.
26. Wolff S: Chromosome aberrations, sister chromatid exchanges and the lesions that produce them. In Wolff S: "Sister Chromatid Exchange." New York: John Wiley & Sons, 1982, pp 41-57.
27. 32P-postlabeling and cytogenetic analysis of human blood treated in vitro with melphalan. Mutagenesis 7:329-333, 1992.
28. Darroudi F, Natarajan AT: Cytostatic drug activity in plasma, a bioassay for detecting mutagenicity of directly and indirectly acting chemicals, an evaluation of 20 chemicals. Mutat Res 143:263-269, 1985.
29. Darroudi F, Natarajan AT: Metabolic activation of chemicals to mutagenic carcinogens by human hepatoma microsomal extracts in Chinese hamster ovary cells (in vitro). Mutagenesis 8:11-15, 1993.
30. Wislocki PG, Miller EC, Miller JA, McCoy EC, Rosenkranz HS: Carcinogenic and mutagenic activities of safrole, 1′-hydroxysafrole, and some known or possible metabolites. Cancer Res 37:1883-1891, 1977.
31. Swanson AB, Chambliss DD, Blomquist JC, Miller EC, Miller JA: The mutagenicities of safrole, estragole, eugenol, trans-anethole and some of their known or possible metabolites for Salmonella typhimurim mutants. Mutat Res 60:143, 1979.
32. Borchert P, Wislocki PG, Miller JA, Miller EC: The metabolism of the naturally occurring hepatocarcinogen safrole to 1′-hydroxysafrole and the electrophilic reactivity of 1′-acetoxysafrole. Cancer Res 33:575-589, 1973.
33. Borchert P, Miller JA, Miller EC, Shires TK: 1′-Hydroxysafrole, a proximate carcinogenic metabolite of safrole in the rat and mouse. Cancer Res 33:590-600, 1973.
34. Wislocki PG, Borchert P, Miller JA, Miller EC: The metabolic activation of the carcinogen 1′-hydroxysafrole in vivo and in vitro and the eletrophilic reactivities of possible ultimate carcinogens. Cancer Res 36:1686-1695, 1976.
35. 6 atom of adenine residues as sites for covalent binding of metabolically activated 1′-hydroxysafrole to mouse liver DNA in vivo. Cancer Res 41:2664-2671, 1981.
36. 1 mice. Carcinogenesis 5:1623-1628, 1984.